Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Forgez

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|October 18, 2012
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesisMariette Baud, Salvatore Strano, Agnes Dechartres, et al.
Biochimie|May 16, 2024
In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: Implication for SARS-cov-2 entry into host cells and susceptibility to COVID-19Matteo Calcagnile, Fabrizio Damiano, Giambattista Lobreglio, et al.
Breast Cancer Research and Treatment|February 22, 2011
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cellsAurélie Courtin, Laudine Communal, Myriam Vilasco, et al.
Plos One|January 22, 2009
The neurotensin receptor-1 pathway contributes to human ductal breast cancer progressionSandra Dupouy, Véronique Viardot-Foucault, Marco Alifano, et al.
Frontiers in Endocrinology|October 25, 2021
Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced ObesityZherui Wu, Nicolas Stadler, Amazigh Abbaci, et al.
Cancer Letters|August 13, 2019
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancerLudovic Fournel, Zherui Wu, Nicolas Stadler, et al.
Oncotarget|September 25, 2014
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in miceSandra Dupouy, Van Kien Doan, Zherui Wu, et al.
Analytical Biochemistry|January 29, 2002
Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studiesOhad Mazor, Marc Hillairet de Boisferon, Alain Lombet, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 30, 2011
Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancerMarco Alifano, Pierre E Falcoz, Valérie Seegers, et al.
Oncotarget|September 25, 2014
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinibMohamad Younes, Zherui Wu, Sandra Dupouy, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Thoracic and Cardiovascular Surgery|October 18, 2012
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesisMariette Baud, Salvatore Strano, Agnes Dechartres, et al.
Biochimie|May 16, 2024
In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: Implication for SARS-cov-2 entry into host cells and susceptibility to COVID-19Matteo Calcagnile, Fabrizio Damiano, Giambattista Lobreglio, et al.
Breast Cancer Research and Treatment|February 22, 2011
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cellsAurélie Courtin, Laudine Communal, Myriam Vilasco, et al.
Plos One|January 22, 2009
The neurotensin receptor-1 pathway contributes to human ductal breast cancer progressionSandra Dupouy, Véronique Viardot-Foucault, Marco Alifano, et al.
Frontiers in Endocrinology|October 25, 2021
Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced ObesityZherui Wu, Nicolas Stadler, Amazigh Abbaci, et al.
Cancer Letters|August 13, 2019
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancerLudovic Fournel, Zherui Wu, Nicolas Stadler, et al.
Oncotarget|September 25, 2014
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in miceSandra Dupouy, Van Kien Doan, Zherui Wu, et al.
Analytical Biochemistry|January 29, 2002
Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studiesOhad Mazor, Marc Hillairet de Boisferon, Alain Lombet, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 30, 2011
Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancerMarco Alifano, Pierre E Falcoz, Valérie Seegers, et al.
Oncotarget|September 25, 2014
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinibMohamad Younes, Zherui Wu, Sandra Dupouy, et al.
Pageof 5